Regulation of the inducible nitric oxide synthase and sodium pump in type 1 diabetes

Medical Hypotheses

Volumn 69, Issue 2, 2007, Pages 302-306

  Zakula, Zorica ^a   Koricanac, Goran ^a   Putnikovic, Biljana ^a,b   Markovic, Ljiljana ^a   Isenovic, Esma R ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b Clinical Medical Center Zemun   (Yugoslavia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); INDUCIBLE NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE A2; PROTEIN KINASE B; SOMATOMEDIN C; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOCRINE EFFECT; COMORBIDITY; ENZYME ACTIVATION; ENZYME REGULATION; GLUCOSE METABOLISM; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; HUMANS; NA(+)-K(+)-EXCHANGING ATPASE; NITRIC OXIDE SYNTHASE TYPE II; RATS;

RATTUS;

EID: 34249730961     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.11.045     Document Type: Article

References (34)

1. +) ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. Diabetologia 29 (1986) 623-628
2. + pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells. Endocrinology 145 (2004) 1151-1160
3. +-pump stimulation by IGF-I in VSMC. Am J Physiol 276 (1999) H2109-H2116
4. +-ATPase gene expression by insulin in vascular smooth muscle cells. Am J Hypertens 6 (1993) 626-629
5. Sowers J.R., and Draznin B. Insulin, cation metabolism and insulin resistance. J Basic Clin Physiol Pharmacol 9 (1998) 223-233
6. Le Roith D. Insulin-like growth factors. N Engl J Med 336 (1997) 633-640
7. Backer J.M., Myers Jr. M.G., Shoelson S.E., Chin D.J., Sun X.J., Miralpeix M., et al. Phosphatidylinositol 3′-kinase is activated by association with IRS-1 during insulin stimulation. Embo J 11 (1992) 3469-3479
8. Zeng G., Nystrom F.H., Ravichandran L.V., Cong L.N., Kirby M., Mostowski H., et al. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101 (2000) 1539-1545
9. Somwar R., Sumitani S., Taha C., Sweeney G., and Klip A. Temporal activation of p70 S6 kinase and Akt1 by insulin: PI 3-kinase-dependent and -independent mechanisms. Am J Physiol 275 (1998) E618-E625
10. Hemmings B.A. Akt signaling: linking membrane events to life and death decisions. Science 275 (1997) 628-630
11. Whiteman E.L., Cho H., and Birnbaum M.J. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab 13 (2002) 444-451
12. Isenovic E.R., Meng Y., Divald A., Milivojevic N., and Sowers J.R. Role of phosphatidylinositol 3-kinase/Akt pathway in angiotensin II and insulin-like growth factor-1 modulation of nitric oxide synthase in vascular smooth muscle cells. Endocrine 19 (2002) 287-292
13. Walsh M.F., Ali S.S., and Sowers J.R. Vascular insulin/insulin-like growth factor-1 resistance in female obese Zucker rats. Metabolism 50 (2001) 607-612
14. Muniyappa R., Srinivas P.R., Ram J.L., Walsh M.F., and Sowers J.R. Calcium and protein kinase C mediate high-glucose-induced inhibition of inducible nitric oxide synthase in vascular smooth muscle cells. Hypertension 31 (1998) 289-295
15. (2+)-dependent translocation domain with homology to PKC and GAP. Cell 65 (1991) 1043-1051
16. Silfani T.N., and Freeman E.J. Phosphatidylinositide 3-kinase regulates angiotensin II-induced cytosolic phospholipase A2 activity and growth in vascular smooth muscle cells. Arch Biochem Biophys 402 (2002) 84-93
17. (+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest 96 (1995) 733-740
18. LaPointe M.C., and Isenovic E. Interleukin-1beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signaling pathways in cardiac myocytes. Hypertension 33 (1999) 276-282
19. (2+)-independent phospholipase A(2) in the regulation of inducible nitric oxide synthase in cardiac myocytes. Hypertension 35 (2000) 249-254
20. Gorin Y., Kim N.H., Feliers D., Bhandari B., Choudhury G.G., and Abboud H.E. Angiotensin II activates Akt/protein kinase B by an arachidonic acid/redox-dependent pathway and independent of phosphoinositide 3-kinase. Faseb J 15 (2001) 1909-1920
21. Grundy S.M., Benjamin I.J., Burke G.L., Chait A., Eckel R.H., Howard B.V., et al. Diabetes and cardiovascular disease: a statement for health care professionals from the American Heart Association. Circulation 100 (1999) 1134-1146
22. Fein F.S. Diabetic cardiomyopathy. Diabetes Care 13 (1990) 1169-1179
23. Galderisi M., Anderson K.M., Wilson P.W., and Levy D. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol 68 (1991) 85-89
24. Rubler S., Sajadi R.M., Araoye M.A., and Holford F.D. Noninvasive estimation of myocardial performance in patients with diabetes Effect of alcohol administration. Diabetes 27 (1978) 127-134
25. Litwin S.E., Raya T.E., Anderson P.G., Daugherty S., and Goldman S. Abnormal cardiac function in the streptozotocin-diabetic rat changes in active and passive properties of the left ventricle. J Clin Invest 86 (1990) 481-488
26. 2+ and NO. Am J Physiol 275 (1998) H823-H830
27. Ren J., Sowers J.R., Walsh M.F., and Brown R.A. Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats. Am J Physiol Heart Circ Physiol 279 (2000) H1708-H1714
28. Kolter T., Uphues I., and Eckel J. Molecular analysis of insulin resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Am J Physiol 273 (1997) E59-E67
29. Redaelli G., Malhotra A., Li B., Li P., Sonnenblick E.H., Hofmann P.A., et al. Effects of constitutive over expression of insulin-like growth factor-1 on the mechanical characteristics and molecular properties of ventricular myocytes. Circ Res 82 (1998) 594-603
30. Sowers J.R. Effects of insulin and IGF-I on vascular smooth muscle glucose and cation metabolism. Diabetes 45 Suppl. 3 (1996) S47-S51
31. 2+ through a wortmannin-sensitive pathway: studies in rat and ferret isolated muscles. Circ Res 83 (1998) 50-59
32. Gerbi A., Barbey O., Raccah D., Coste T., Jamme I., Nouvelot A., et al. Alteration of Na, K-ATPase isoenzymes in diabetic cardiomyopathy: effect of dietary supplementation with fish oil (n-3 fatty acids) in rats. Diabetologia 40 (1997) 496-505
33. (+)-ATPase in rat arterial smooth muscle. Am J Physiol 273 (1997) E113-E121
34. (+)-ATPase activity via PI3K/Akt pathway in vascular smooth muscle cells. Int J Mol Med 13 (2004) 915-922